Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $0.01 USD
Change Today +0.0002 / 2.00%
Volume 938.8K
EAPH On Other Exchanges
As of 8:10 PM 05/28/15 All times are local (Market data is delayed by at least 15 minutes).

easton pharmaceuticals inc (EAPH) Snapshot

Previous Close
Day High
Day Low
52 Week High
01/28/15 - $0.04
52 Week Low
12/22/14 - $0.0060
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

Related News

No related news articles were found.

easton pharmaceuticals inc (EAPH) Related Businessweek News

No Related Businessweek News Found

easton pharmaceuticals inc (EAPH) Details

Easton Pharmaceuticals Inc., a specialty pharmaceutical company, designs, develops, and markets various topically delivered drugs and therapeutic health care products. Its products include Nauseasol, a motion sickness gel; Skin Renou HA, an anti-aging wrinkle cream using hyaluronic acid, which keeps the skin smooth; Kenestrin Gel used for arthritis, knees, elbows, shoulders, wrist, and back pain; Viorra, a hormone free, non-toxic, and topical gel that improves sexual functioning of women; and female sexual arousal disorder drug. The company is also developing XILIVE, an early stage cancer drug. In addition, it is involved in the medical marijuana business. The company was formerly known as LAM Industries, Inc. and changed its name to Easton Pharmaceuticals Inc. in March 2010. Easton Pharmaceuticals Inc. was founded in 1997 and is based in Toronto, Canada.

easton pharmaceuticals inc (EAPH) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

easton pharmaceuticals inc (EAPH) Key Developments

Easton Seeks Acquisitions

Easton Pharmaceuticals Inc. may need additional financing to fund other initiatives and possible acquisitions.

Easton Pharmaceuticals Inc. Launches First 3 OTC Products

Easton Pharmaceuticals Inc. announced it has successfully launched its first 3 OTC Products at the recently attended Total Health Show and Yoga Show, proceeds towards completion of its 2014 year end audit. Easton announced that its first 3 main OTC products are now ready to be ordered directly through its distributor Nutrashop Global Stores and on Eastons own website. The products received extremely favorable reviews at the first two trade shows and was one of the top selling exhibitors out of the estimated 300 hundred in attendance. The company's proprietary gel formulation is an innovative and unique transdermal delivery system, currently incorporated into 3 of its OTC therapeutic products with near term plans for another 3 products. Easton Pharmaceuticals' VIORRA product, is an over-the-counter aid for the treatment to restore and improve vaginal moisture and elasticity which has a very positive effect on women's sexual desire and arousal, FSAD the world market for these female conditions are in excess of $2 billion. VIORRA is a topical, daily-use product classified by the FDA as containing Generally Recognized as Safe ingredients. Kenestrin Gel is a pain relieving gel designed to help relieve pain associated with arthritis and other types of pain including lower back where initial feedback on effectiveness has been positive. Skin Renou HA drew the biggest initial response at the health show due to the broad volume of samples made available which has resulted in many inquiries for distribution. Now that the products have been launched and are ready to ship, BMV Medica SA, its partners in Mexico and Latin America, is now able to distribute the products through its broad distribution channels in the region to coincide with the previously announced distribution agreement where Easton and BMV are the sole exclusive distributors in Mexico for the VS-Sense woman's diagnostic patented product which is currently being sold throughout North America.

Easton Pharmaceuticals Inc. Finalizes Joint Partnership Agreement with BMV Medica SA de C.V. for Rights to Distribute Patented Women's Health Diagnostic Test in Mexico from Common Sense Ltd

Easton Pharmaceuticals Inc. announced that it has entered into a 50/50 revenue sharing partnership with BMV Medica SA de C.V. for a distribution agreement with Common Sense Ltd. of Israel to become the distributor in the country of Mexico for their patented woman's diagnostic Vaginal Infection Test, currently being sold throughout the United States, Canada and soon Europe. Both companies announced that they have obtained distribution rights for the country of Mexico from Common Sense Ltd. and their patented product line known as VS-SENSE-OTC and VS-SENSE PRO, for the detection of Bacterial Vaginosis (BV) and Trichomonas. Easton and BMV have allocated funds towards regulatory filings in Mexico, which will be submitted by contracted, industry respected regulatory consultants. Additional funds have been allocated and set aside towards branding and packaging. The regulatory approval in Mexico is anticipated to be quickly passed by the country's health agency due to necessity and the fact the products are currently approved for sale in North America and Europe.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
EAPH:US $0.01 USD +0.0002

EAPH Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for EAPH.
View Industry Companies

Industry Analysis


Industry Average

Valuation EAPH Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact EASTON PHARMACEUTICALS INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at